Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France · Delayed Price · Currency is EUR 0.3420
+0.0010 (0.29%)
At close: Jun 23, 2026
EPA:ALOPM Market Cap
EPA:ALOPM has a market cap or net worth of €6.51 million as of June 23, 2026. Its market cap has increased by 15.62% in one year.
Market Cap
6.51M
Enterprise Value
10.78M
Revenue
1.81M
Ranking
n/a
PE Ratio
1.14
Stock Price
€0.34
Market Cap Chart
Since October 5, 2022, EPA:ALOPM's market cap has increased from 5.82M to 6.51M, an increase of 11.82%. That is a compound annual growth rate of 3.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 6.51M | -12.78% |
| Dec 31, 2025 | 7.47M | -42.44% |
| Dec 31, 2024 | 12.97M | -56.74% |
| Dec 29, 2023 | 29.99M | 155.14% |
| Dec 30, 2022 | 11.75M | 101.80% |
| Oct 5, 2022 | 5.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 22.13M |
| GenSight Biologics | 19.34M |
| Advicenne | 15.83M |
| Aelis Farma | 13.19M |
| Poxel | 11.18M |
| NFL Biosciences | 10.39M |
| Aton | 9.11M |
| TME Pharma | 6.90M |